Safety Study of PI-0824 to Treat Pemphigus Vulgaris

Status:
Completed

Trial end date:
2005-03-01

Target enrollment:

Participant gender:

The purpose of this study is to determine if the use of PI-0824 in patients with Pemphigus vulgaris is safe.

Phase 1

Peptimmune